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CPEB-mediated translation is important in early development and neuronal synaptic plasticity. Here, we
describe a new eukaryotic initiation factor 4E (eIF4E) binding protein, Neuroguidin (Ngd), and its interaction
with CPEB. In the mammalian nervous system, Ngd is detected as puncta in axons and dendrites and in growth
cones and filopodia. Ngd contains three motifs that resemble those present in eIF4G, 4EBP, Cup, and Maskin,
all of which are eIF4E binding proteins. Ngd binds eIF4E directly, and all three motifs must be deleted to
abrogate the interaction between these two proteins. In injected Xenopus oocytes, Ngd binds CPEB and, most
importantly, represses translation in a cytoplasmic polyadenylation element (CPE)-dependent manner. In
Xenopus embryos, Ngd is found in both neural tube and neural crest cells. The injection of morpholino-
containing antisense oligonucleotides directed against ngdmRNA disrupts neural tube closure and neural crest
migration; however, the wild-type phenotype is restored by the injection of a rescuing ngd mRNA. These data
suggest that Ngd guides neural development by regulating the translation of CPE-containing mRNAs.
The regulated translation of specific mRNAs influences a
large number of biological processes, including meiotic pro-
gression (39, 60), the mitotic cell cycle (25, 46), and body axis
specification (44, 50). In the adult nervous system, translational
control modifies synaptic efficacy (29, 32), which probably un-
derlies long-term memory storage (40). In developing neurons,
translation is important for axon guidance (9, 10, 68). While
several regulatory proteins probably control translation during
these cellular processes, at least one, CPEB, appears to be
involved in them all. CPEB was identified as the cytoplasmic
polyadenylation element (CPE) binding factor in Xenopus oo-
cytes (27, 36). When these cells are stimulated to reenter the
meiotic divisions, several dormant CPE-containing mRNAs
that have short poly(A) tails undergo poly(A) elongation;
translational activation is the result of this elongation (6, 60).
The mechanism by which cytoplasmic polyadenylation in-
duces translation was elucidated in Xenopus oocytes. Here, a
CPEB-associated factor, Maskin, was shown to be a key regu-
latory molecule: it binds not only CPEB, but also the cap
binding factor eukaryotic initiation factor 4E (eIF4E) (59).
The site on eIF4E that interacts with Maskin is the same as
that normally occupied by eIF4G, a scaffold protein that is
necessary for translation because it (indirectly) recruits the 40S
ribosomal subunit to the 5 untranslated region (UTR) of the
mRNA. Thus, Maskin is an inhibitor of translation because it
precludes the interaction of eIF4G and eIF4E. In this sense,
Maskin is functionally similar to the 4EBPs (47, 49), factors
that inhibit translation by interfering with the eIF4E-eIF4G
association. However, Maskin is an unusual 4EBP because its
tethering to CPEB makes it a message-specific translation-
inhibitory protein.
The inhibition of translation by the 4EBPs is reversible and
is dictated by their state of phosphorylation (23). Maskin in-
hibition is also reversible, but in this case, both cytoplasmic
polyadenylation and phosphorylation are the important regu-
latory events. During oocyte maturation, progesterone induces
the inactivation of glycogen synthase kinase 3, which in turn is
necessary for the activation of Aurora A (also known as Eg2
[2]), a serine/threonine kinase (52). Aurora A phosphorylates
CPEB serine 174, an event that enhances the interaction be-
tween CPEB and cleavage and polyadenylation specificity fac-
tor; such an interaction may help cleavage and polyadenylation
specificity factor stably associate with a second important cis
element, AAUAAA (37, 38). In a mechanism that is as yet
unknown, CPEB phosphorylation stimulates the activity of
Gld2, an unusual poly(A) polymerase that catalyzes poly(A)
addition (6). The newly elongated poly(A) associates with
poly(A) binding protein (PABP); PABP also binds eIF4G.
PABP-bound eIF4G then out-competes Maskin for binding
to eIF4E, the result of which is the initiation of translation
(11). During maturation, Maskin also undergoes a number
of phosphorylation events that also help it to dissociate from
eIF4E (5).
In addition to oocytes, CPEB has been detected in the mam-
malian central nervous system, where it has been found to
reside at postsynaptic sites (67). The stimulation of synapses by
visual experience or N-methyl-D-aspartate receptor activation
results in the polyadenylation and translation of the CPE-
containing CaMKII and other mRNAs (19, 28, 54, 64, 67). In
addition, CPEB knockout mice have deficits in long-term po-
tentiation and hippocampus-dependent memories (1, 7). At
synapses, many of the factors involved in polyadenylation-in-
duced translation have been detected (28); however, other
proteins, particularly those with a possible Maskin-like activity,
also may function in the nervous system. In this regard, the
product of another gene, which we call Neuroguidin (ngd),
functions in the Drosophila embryonic nervous system (L.
Lorenz et al., unpublished data). Here, we show that Ngd
resembles Maskin in that it interacts with eIF4E through a
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discrete binding motif. The protein is widely expressed in the
mammalian nervous system and is often detected as puncta
that resemble RNP particles in axons and dendrites, as well as
in growth cones and lamellipodia. In addition to eIF4E, Ngd
also interacts with CPEB, and in injected Xenopus oocytes, it
inhibits mRNA translation in a CPE-dependent manner. In
Xenopus embryos, Ngd is found in the embryonic nervous
system and neural crest. The injection of morpholino-contain-
ing antisense oligonucleotides against Ngd RNA results in a
failure of neural tube closure and inhibited neural crest cell
migration. These data indicate that Ngd functions as an im-
portant translational regulatory protein during development of
the vertebrate nervous system.
MATERIALS AND METHODS
Plasmid construction and Northern blotting. Based on homology with Dro-
sophila ngd, a mouse ngd cDNA was obtained and cloned into EcoRI/BamHI-
digested pBluescriptII SK and BglII/BamHI-digested pET-30a. Xenopus ngd was
amplified by reverse transcription-PCR from total RNA of stage V and VI stage
oocytes and cloned into BamHI/SalI-digested pBluescriptII SK. Twenty micro-
grams of total RNA was resolved by formaldehyde/agarose gel electrophoresis
and probed with 32P-labeled random-primed Ngd DNA.
Generation of Ngd antibody and Western blotting. The mouse ngd open
reading frame was cloned behind a histidine tag in pET-30a, expressed in Esch-
erichia coli, and isolated on an Ni column, which was used to generate antisera.
For Western blotting, tissue or cell cultures were homogenized in 10 volumes of
HB buffer (0.1 M KCl, 1 mM MgCl2, 50 mM Tris-HCl [pH 7.5], 0.5% Triton
X-100, and 10 g/ml each of the protease inhibitors pepstatin, chymostatin, and
leupeptin), and 50 g of protein was probed with antibodies against Ngd, CPEB,
Maskin, dynein (Chemicon), eIF4E (Transduction Laboratories), extracellular
signal-regulated kinase 2 (ERK2) (Santa Cruz), or tubulin (Sigma).
Coimmunoprecipitation and cap column assays. Groups of 15 oocytes were
homogenized in 150 l of HB buffer containing RNase A (0.1 mg/ml) and
centrifuged, and the postmitochondrial supernatant was preabsorbed to protein
A-Sepharose for 1 h at 4°C. The solution was then added to antibody-bound
protein A-Sepharose beads, which were prepared by mixing 25 l of protein
A-Sepharose and 10 l of preimmune or immune serum at 4°C overnight and
then washing with HB buffer. Immunoprecipitation was performed for 4 h at 4°C,
after which the beads were washed with HB buffer and then boiled in sodium
dodecyl sulfate (SDS) sample buffer.
Whole mouse brain or cerebellum was homogenized in HB buffer containing
RNase A and centrifuged to pellet insoluble material, and the supernatant was
subjected to immunoprecipitation as described above or to cap column chroma-
tography as described previously (59).
Ngd-eIF4E binding assay. The mouse Ngd sequence containing or lacking the
putative eIF4E binding motifs was cloned into pRSET (Invitrogen). These clones
and DNA encoding human eIF4E (59) were expressed in E. coli. Protein G-
Sepharose 4B was bound with eIF4E antibody and eIF4E and then mixed with
the Ngd proteins at 4°C for 2 h. Bacterial extracts were prepared in 100 mM KCl,
1 mM MgCl2, 50 mM Tris-Cl (pH 8.0), 1 mM dithiothreitol, 0.4% NP-40, 50 g
of RNase A, and protease inhibitor cocktail (Roche); the whole extracts were
used for binding assay. The protein G beads were boiled in SDS sample buffer,
and the bound proteins were analyzed by Western blotting.
CAT assays. CAT-CPE and CAT-CPE mRNAs have been described pre-
viously (62). Stage VI oocytes were coinjected with mRNAs (8 ng) and Ngd
(16 ng) or buffer. Two hours after injection, the oocytes were collected for
chloramphenicol acetyltransferase (CAT) assays as described previously (17).
Some oocytes were injected with [32P]UTP-labeled CAT-CPE or CAT-CPE
mRNA and Ngd protein and then assessed for RNA stability on a denaturing
polyacrylamide gel.
Immunohistochemistry. Brain and spinal cord sections were obtained from
Novagen Co. and from C. Jung (30). Rehydrated paraffin sections were fixed with
4% paraformaldehyde in phosphate-buffered saline (PBS) for 15 min; blocked
with 10% goat serum, 5% bovine serum albumin, and 0.1% Triton X-100 in PBS
at 4°C overnight; and probed with primary antibody (Ngd or neurofilament) and
then secondary antibody (Alexa 546- or 488-labeled goat anti-rabbit immuno-
globulin G [IgG] or Alexa 546- or 488-labeled goat anti-mouse IgG [Molecular
Probes]). Some sections were incubated with biotinylated horse anti-rabbit IgG
(Vectastain ABC kit; Vector Laboratories) for 90 min at room temperature after
primary antibody incubation with Ngd antibody, followed by diaminobenzidine
staining as described previously (31).
Hippocampal neuron cultures and immunocytochemistry. Embryonic rat hip-
pocampal neurons were cocultured with glial cells at a density of 5,000 to 20,000
cells/cm2 (4, 16). The coverslips were rinsed with PBS, fixed with 4% paraform-
aldehyde in PBS for 15 min, and permeabilized with 0.1% Triton X-100 in PBS
for 3 min. They were blocked with 10% goat serum and 5% bovine serum
albumin in PBS for 1 h at 37°C, incubated at 37°C for 2 h with primary antibodies,
and then incubated again at 37°C for 90 min with secondary antibody. Some
neurons were labeled for filamentous actin with Alexa 488-conjugated phalloidin
at 0.2 unit per coverslip in PBS for 1 h at 37°C.
Analysis of Xenopus embryos. In situ hybridization to Xenopus material in
whole mount and on sections (10 m) was carried out as described previously
(55; http://www.hhmi.ucla.edu/derobertis/). Probes for slug and nrp-1, which have
been described elsewhere (35, 48), were labeled with digoxigenin-UTP according
to standard methods (Roche) and reacted with alkaline phosphatase-conjugated
digoxigenin antibody. A standard control morpholino oligonucleotide (CM) and
Xenopus ngd antisense morpholino oligonucleotide (AM) directed against the 5
UTR and the first 4 bases of the open reading frame consisting of 5-CCATTG
TACCCCACGTCTGTGTTAC were purchased from Gene Tools. Phenotype
rescue experiments entailed the coinjection of oligonucleotides (3 ng) with in
vitro-synthesized ngd mRNA (2 ng).
RESULTS
Ngd in the vertebrate nervous system. The distribution of
ngd mRNA in mouse tissues was determined by Northern
blotting. With the exception of muscle, ngd mRNA was de-
tected in all tissues examined, including several parts of the
brain, kidney, spleen, ovary, and testis (Fig. 1A). To assess Ngd
protein, a mouse ngd cDNA was expressed in E. coli, purified,
and used to immunize rabbits. The antibody was affinity puri-
fied (Fig. 1B) and used to probe a Western blot of protein from
several different mouse tissues (Fig. 1C). As with the RNA gel
blot described above, Ngd protein was detected in all tissues
except muscle; it was also detected in cultured hippocampal
neurons and glia.
To obtain more precise information on Ngd expression in
the central nervous system, immunohistochemistry was per-
formed on sagittal sections of adult mouse brain. High immu-
noreactivity was detected in all parts of the hippocampus, par-
ticularly the dentate gyrus, and the cerebellum (Fig. 1D and E,
top panels) (note the heavy brown diaminobenzidine stain
used to detect Ngd). Ngd expression was further examined
using double-antibody-labeled immunofluorescence micros-
copy (Fig. 1D and E, lower panels). Unphosphorylated neuro-
filament in green served as a specific marker for neurons; its
immunoreactivity was found only in the perinuclear space as
well as in dendrites. Ngd (red) was detected in hippocampal
neurons (Fig. 1D) and in the granule cell layer and Purkinje
cells of the cerebellum (Fig. 1E). The Ngd immunoreactivity
was punctate in appearance and was evident in the nucleus and
the cytoplasm. Ngd particles were also found in the adult spinal
cord, where the highest immunoreactivity was detected in ven-
tral motor neurons (Fig. 1F, top and bottom panels).
Localization of Ngd in cultured neurons. Hippocampal neu-
rons undergo characteristic morphological changes as they ma-
ture both in vivo and in vitro (4). To determine whether Ngd
expression correlated with any of these changes, neurons were
cultured for various times and immunostained with Ngd antibody;
Alexa-labeled phalloidin, which binds to filamentous actin, served
as a counterstain. After 4 hours of culture, most of the Ngd
immunoreactivity was detected in the soma, in both nuclear and
cytoplasmic compartments. In neurites, Ngd particles were clearly
4278 JUNG ET AL. MOL. CELL. BIOL.
 at UNIV O
F M
ASS M








detected along the edges of the motile lamellipodia of growth
cones (Fig. 2A). At 24 h of culture, Ngd again was predominantly
in the soma, but Ngd particles were also observed in growth
cones, often at the tips of filopodia (Fig. 2B). After 14 days of
culture, when the neurons are fully differentiated, Ngd particles
were observed in neurites, particularly near the base and in the
shaft and tips of filipodia (Fig. 2C, panels 1 to 4). To more clearly
differentiate between axon and dendritic Ngd staining, 14-day
cultures were costained with antibody against Map2, a dendritic
marker, or with phosphoneurofilament (P-NP), an axonal
marker. Figure 2D shows Ngd particles on or near Map2-postive
dendrites. However, this staining was consistent not only with
dendritic staining but also with a situation where Ngd-containing
axons possibly formed a sheath around the dendrites. Figure 2D
(panel 6) shows clear Ngd immunostaining in a neurite where
there was no Map2 immunostaining, pointing to a likely presence
of Ngd in axons. This possibility was confirmed in Fig. 2E (panel
7), where Ngd immunostaining was coincident with P-NP immu-
nostaining, an axon marker. However, Fig. 2E (panel 8) shows
Ngd particles in large neurites that did not immunostain with
FIG. 1. Tissue distribution of mouse Ngd. (A) Northern blotting analysis of total RNA (20 g) from several adult mouse tissues probed for ngd.
(B) Western analysis of mouse brain extract (50 g), using preimmune and Ngd immune serum, and affinity-purified Ngd antibody. Ab, antibody.
(C) Western analysis of protein (50 g) from several adult mouse tissues as well as cultured rat hippocampal neurons (14-day cultures) or cultured
rat cortical glial cells probed with affinity-purified Ngd antibody. (D and E) Immunohistochemistry of Ngd in the hippocampus and cerebellum of
adult mouse brain. Sagittal sections of paraffin-embedded tissue were probed with Ngd antibody followed by horseradish peroxidase-conjugated
anti-rabbit IgG. Similar sections were also doubly immunostained with antibodies for Ngd (red) and unphosphorylated neurofilament (green); the
boxes denote approximate corresponding areas between the two sections. N, nucleus; C, cytoplasm; GL granule cell layer; scale bars, 10 m.
(F) Immunofluorescent images of sagittal sections of an adult mouse spinal cord. To better demonstrate high Ngd immunoreactivity in motor
neurons, an image taken of the ventral part of a spinal cord section (top panel) was magnified (lower panel).
VOL. 26, 2006 TRANSLATIONAL CONTROL BY Neuroguidin 4279
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FIG. 2. Ngd localization in cultured rat hippocampal neurons. (A to C) Images of Ngd immunofluorescence (green) in primary hippocampal
neurons cultured for 4 h (A), 24 h (B), or 14 days (C). Phalloidin (red), which binds to F-actin, helps to define the morphology of cells and growth
cones. Ngd immunoreactivity was observed at the edges (open arrows) and tips (asterisks) of growth cones and filopodia; Ngd was also strongly
detected in the cell body. Open arrowheads denote Ngd expression at the base and in the shaft of filopodia (C). (D and E) Immunofluorescent
images of Ngd (green) and Map2 (red in panel D), which identifies dendrites, or phosphorylated neurofilament (red in panel E), which identifies
axons in 14-day-old hippocampal neurons. Ngd-containing particles were detected in both axons and dendrites. The middle panels show neuron
morphology by bright-field imaging. Scale bars, 10 m.
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P-NP and hence are dendrites. In summary, Ngd resides in par-
ticles in neurons of all stages; the particles are present in axons
and dendrites and are detected in filopodia. Also, Ngd is not
particularly colocalized with PSD95, a synaptic marker.
Ngd interacts with eIF4E. The mouse, human, and Xenopus
Ngd protein sequences are shown in Fig. 3A. The mouse and
human sequences are 89% identical, whereas the mouse and
Xenopus sequences are 61% identical. Residues 103 to 116 are
particularly well conserved among these three animals; these
residues are also very highly conserved in Drosophila Ngd
(93% relative to the mouse), which has only a 38% overall
identity with the mouse protein. These residues resemble a
motif that is present in proteins that bind the cap binding
factor eIF4E (Fig. 3A, lower panel) (33, 34, 49, 58). These
proteins include Xenopus Maskin (which alone among eIF4E
binding proteins contains a threonine at position 6 of this
motif), eIF4G, and 4EBP1. Of these factors, eIF4G binding to
eIF4E is the only one that is required for translation; the other
factors inhibit translation by competing with eIF4G for binding
to eIF4E. Ngd contains two additional putative eIF4E binding
regions that are similarly conserved.
To determine whether Ngd resides in a complex with eIF4E,
an extract prepared from adult mouse brain was supplemented
with GTP (0.2 mM) and RNase A (0.1 mg/ml) and applied to
a column containing 7mGTP affixed to Sepharose (cap col-
umn). In some cases, the extract was supplemented with 0.2
mM free cap (7mGTP) in place of GTP. Following extensive
washing, the Sepharose beads were boiled in SDS sample
buffer and the retained protein was subjected to Western blot-
ting. Figure 3B (left panel) shows that in the presence of free
GTP, both eIF4E and Ngd were retained on the cap column.
When the extract contained free 7mGTP, most of the eIF4E
and all of the Ngd were out-competed for binding to the cap
beads. These data suggest that Ngd was retained on the cap
column through an interaction with eIF4E. To assess this fur-
ther, an extract from mouse cerebellum was supplemented
with RNase A and subjected to an immunoprecipitation pro-
cedure with eIF4E antibody; Western analysis demonstrates
that eIF4E was indeed immunoprecipitated, as was Ngd. When
preimmune serum was used in the initial immunoprecipitation,
neither eIF4E nor Ngd was detected on the Western blot (Fig.
3B, second panel). In a reciprocal experiment, Ngd antibody
precipitated not only Ngd but eIF4E as well (Fig. 3B, third
panel). ERK2 was not coimmunoprecipitated with Ngd anti-
body and hence served as a negative control. These data indi-
cate that eIF4E and Ngd reside in a multiprotein complex in
the mouse brain.
We next determined which Ngd residues are necessary for
interacting with eIF4E. The putative eIF4E biding motifs high-
lighted in Fig. 3A were sequentially deleted, and the proteins
were expressed in bacteria and mixed with E. coli-expressed
eIF4E (in the presence of 50 g/ml RNase A), which in turn
was bound to eIF4E antibody tethered to protein G beads. The
bound proteins were then analyzed by Western blotting (Fig.
3B, fourth panel). Compared to wild-type Ngd, deletion of
motif 2 or motifs 1 and 2 had little effect on binding to eIF4E.
Deletion of motifs 2 and 3 lowered binding to eIF4E by about
50%, while deletion of all three motifs completely abolished
Ngd binding to eIF4E. These results indicate that all three
motifs can contribute to binding to eIF4E and that they can
compensate for one another.
If Ngd acts as a negative regulator of translation by binding
eIF4E, these two proteins should colocalize. On the other
hand, the interaction between Ngd and eIF4E may be regu-
lated, and thus their binding may only be transient. In spite of
this caveat, we performed double immunostaining for Ngd and
eIF4E on neurites and growth cones of cultured hippocampal
neurons cultured for 3 days (Fig. 3C). Both Ngd and eIF4E
were readily detected, and surprisingly, as much as 21% of the
eIF4E was colocalized with Ngd. Thus, four different assays,
i.e., cap column chromatography, antibody coimmunoprecipi-
tation, mutagenesis followed by protein-protein interaction in
vitro, and immunocytochemistry, all consistently point to an
interaction between Ngd and eIF4E.
Ngd inhibits translation in a CPE-dependent manner. Ngd,
like Maskin, might interact with a sequence-specific RNA
binding protein. This possibility, together with its expression in
neurons, prompted us to determine whether it might associate
with CPEB and, if so, whether it controls translation in a
CPE-dependent manner (11, 60). We examined Ngd activity in
the injected Xenopus oocyte, which is a well-characterized sys-
tem to study CPEB-mediated translation. Initially, we tested
whether Ngd interacts with CPEB by coimmunoprecipitation
analysis. Although Xenopus oocytes contain ngd mRNA, they
do not contain detectable Ngd protein (see Fig. 5A). Conse-
quently, we injected recombinant NgD (Fig. 4A, left panel)
into stage VI oocytes; 2 hours later, extracts were subjected to
coimmunoprecipitation with Ngd and CPEB antibodies. As
shown by Western blotting (Fig. 4A, right panel), Ngd antibody
precipitated not only Ngd but also CPEB (lane1); preimmune
serum precipitated neither CPEB nor Ngd (lane 2). Recipro-
cally, CPEB antibody coimmunoprecipitated Ngd along with
CPEB (lane 3), demonstrating that Ngd and CPEB were in the
same complex.
Next, we addressed whether Ngd could inhibit translation in
vivo. mRNAs encoding CAT were fused to the cyclin B1 3
UTR, which contains three CPEs (CAT-CPE), or to one in
which the CPEs have been mutated (CAT-CPE) (62). They
were mixed with recombinant Ngd or buffer and injected into
oocytes; 2 hours later, extracts were prepared for CAT assays.
The CPE is a repressor as well as an activator element (18) and
serves to anchor Maskin indirectly through CPEB (4, 59). In
the absence of Ngd, the CPE inhibited translation of the CAT
reporter by 40% (data not shown). A further 51% reduction
of CAT activity was obtained when the CAT-CPE mRNA
was injected together with Ngd. Ngd did not affect the trans-
lation of CAT-CPE mRNA (Fig. 4B). The Ngd-mediated
reduction of CAT activity derived from CAT-CPE RNA was
statistically significant (P  0.01, Student’s t test). To ensure
that the two mRNAs were equally stable, oocytes were injected
with [32P]UTP-labeled CAT-CPE and CAT-CPE mRNAs
together with Ngd or buffer and cultured for 2 hours; the RNA
was then extracted and analyzed on a denaturing gel. Figure 4B
(bottom) shows that the RNAs were stable. These results dem-
onstrate that Ngd inhibits the translation of CPE-containing
mRNAs.
Control of neural tube closure and neural crest migration by
Ngd. To assess the possible function of Ngd in the vertebrate
nervous system, we examined developing Xenopus embryos
VOL. 26, 2006 TRANSLATIONAL CONTROL BY Neuroguidin 4281
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FIG. 3. Ngd is an eIF4E binding protein. (A) Alignment of mouse, human, and Xenopus Ngd sequences. The residues (boxed) correspond to
putative eIF4E binding domains. The lower part of the panel shows a limited alignment of several eIF4E binding proteins; those residues that are
particularly well conserved are in boldface. The boxed areas denote putative eIF4E binding regions. (B) Interaction between Ngd and eIF4E. The
first panel shows a cap column assay in which an adult mouse brain extract was supplemented with GTP (0.2 mM) and RNase A (0.1 mg/ml) and
applied to a 7mGTP-Sepharose column. In one case, the extract also contained free 7mGTP (0.2 mM). Proteins that were retained on the column
were probed for the presence of Ngd and eIF4E. abs, antibodies. The second panel shows an eIF4E coimmunoprecipitation assay in which a mouse
cerebellum extract was immunoprecipitated (IP) with preimmune serum (PI) or eIF4E immune serum (IM) and the material probed for the
presence of Ngd and eIF4E. The third panel shows a similar coimmunoprecipitation assay using Ngd antibody; the precipitated proteins were
probed for the presence of Ngd, eIF4E, and ERK2, a negative control. The fourth panel shows binding assays between mutant Ngd proteins and
eIF4E. The top blot shows that equal amounts of eIF4E were bound to eIF4E antibody beads, the second blot demonstrates that similar amounts
of Ngd proteins were incubated with the eIF4E-containing antibody beads, and the third blot shows the amount of Ngd bound to the eIF4E beads.
(C) Images of Ngd (green) and eIF4E (red) immunofluorescence in a hippocampal neuron cultured for 3 days. The arrows show regions where
these two proteins colocalized. Scale bar, 10 m.
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because they are amenable to loss-of-function experiments by
injection of antisense oligonucleotides. As noted previously,
oocytes contain no detectable Ngd protein, nor do early em-
bryos; by Western analysis, Ngd was detected only from the
early tailbud stage (Fig. 5A). Interestingly, steady-state Maskin
levels inversely correlated with Ngd; Maskin was present in
oocytes and early embryos but diminished in tailbud stage
embryos (Fig. 5A, left and right panels). Coupled with the
functional data presented in Fig. 4, such an inverse correlation
suggests that Ngd is the main regulator of CPE-dependent
translation in later development.
We examined ngd mRNA expression in embryos by whole-
mount in situ hybridization. ngd mRNA was weakly detected in
animal pole blastomeres of the four-cell embryo and in the neural
crest and neural folds of the neurula stage embryo (Fig. 5B, upper
panel), specifically in the lateral cranial neural folds and in the
center of the neural plate. As a control, a sense probe for Ngd
never resulted in any detectable signal (data not shown). Addi-
tional in situ hybridizations with the neural crest marker slug and
the pan-neural marker nrp-1 (Fig. 5B, bottom panels) demon-
strated that ngd mRNA was present not only in the spinal cord
but also in the brain and eyes and in trunk cells and branchial
arches, both of which are derived from the neural crest.
The injection of a morpholino-containing antisense oligonu-
cleotide (AM) inhibits the translation of a target mRNA (61),
allowing one to score for a loss-of-function phenotype. Using
this approach, we first tested the efficacy of an ngd AM di-
rected against the Xenopus ngd 5 UTR to inhibit the transla-
tion of ngd mRNA in a rabbit reticulocyte lysate. As shown in
Fig. 6A, the ngd AM completely blocked translation of full-
length ngd mRNA in a dose-dependent manner; however, a
control morpholino oligonucleotide (CM) had no effect on
translation even at a relatively high concentration of 10 M.
Based on these results, embryos were injected with AM or CM
and cultured until the CM-injected embryos reached the tad-
pole stage. The injection of ngd AM resulted in abnormally
patterned embryos, particularly along the medial region nor-
mally occupied by the neural tube (Fig. 6B). In situ hybridiza-
tion with the pan-neural marker nrp-1 shows what appears to
be a bifurcated neural tube or an unclosed neural tube in stage
25 tailbud embryos (Fig. 6B, right panel). The injected em-
bryos were further analyzed by performing nrp-1 in situ hybrid-
ization on sectioned material derived from paraffin-embedded
samples (Fig. 6C). Compared to a CM-injected embryo that
had a normal neural tube (left panel), an ngd AM-injected
embryo displayed a neural tube that failed to close Fig. (6D).
This phenotype occurred in 36% of injected embryos; CM-
injected embryos showed a similar phenotype only about 2% of
the time, a difference that is very highly statistically significant
(P  0.001, Student’s t test) (Fig. 6E). To rescue the morpho-
lino-induced phenotype, ngd AM was mixed with in vitro-syn-
thesized ngd mRNA that lacked the region in the 5 UTR that
would anneal with the AM (to allow initiation on the proper
AUG codon). Embryos injected with this mixture displayed
abnormal phenotypes similar to those mentioned above only
20% of the time (Fig. 6F). This amount of rescue was statisti-
cally significant (P  0.05, Student’s t test).
Additional ngd AM-injected embryos were analyzed by in
situ hybridization with slug, a neural crest marker. Figure 6F
(CM) shows a normal pattern of slug RNA expression in stage
25 embryos, where hybridization was evident in the branchial
arches and the trunk neural crest (35). In AM-injected em-
bryos, the branchial arches were reduced and the migration of
neural crest cells to the midline was inhibited (injected side).
The percentage of AM-injected embryos that exhibited this
phenotype (56%, 20 of 36 injected embryos) was much greater
than that of CM-injected embryos (5%, 2 of 36 injected em-
bryos). Moreover, when the AM was mixed with in vitro-syn-
thesized ngd mRNA lacking the 5 UTR region corresponding
FIG. 4. Ngd inhibits translation in a CPE-dependent manner.
(A) CPEB and Ngd can be coimmunoprecipitated. Mouse Ngd, over-
expressed in and purified from E. coli (left panel shows a Coomassie
blue-stained gel) was injected into Xenopus oocytes. After 2 h of
culture, Ngd and CPEB antibodies (Abs), as well as preimmune serum
(PI), were used for coimmunoprecipitation assays; the resulting West-
ern blots were probed for CPEB and Ngd. The arrow denotes the
heavy chain of IgG. MW, molecular weight markers. (B) A schematic
diagram of the CAT reporter mRNAs, containing or lacking CPEs,
that were injected into oocytes is illustrated. The RNAs (8 ng) were
mixed with buffer or with purified Ngd protein (16 ng), and injected
into stage VI oocytes (Ngd or Ngd). Two hours after injection, the
oocytes were collected and used for CAT assays. The graph shows the
ratio of CAT activity from oocytes of four different frogs injected with
Ngd or buffer (Ngd/Ngd) for both CPE-lacking and CPE-containing
mRNAs. The asterisk denotes statistical difference between the groups
(P  0.01, Student’s t test). Error bars indicate standard deviations.
The bottom part shows the relative stability of 32P-labeled mRNAs
(CAT-CPE and CAT-CPE) injected in the presence or absence of
Ngd; the oocytes were collected 2 hours after injection.
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to the annealing morpholino prior to injection, only 24% ex-
hibited a phenotype (8 of 33 injected embryos). Taken to-
gether, these results suggest that Ngd is important not only for
neural tube closure but also for the neural crest cell migration.
DISCUSSION
Short sequence elements that reside in the 3 untranslated
regions of many mRNAs modulate translational repression
and activation. Although specific proteins have often been
shown to bind these sequences, with few exceptions, the mech-
anism by which they exert their presumed translational regu-
latory effects is unknown. In the case of CPEB, a factor with
which it associates, Maskin, is the proximal regulator of trans-
lation; its control of initiation is dependent upon a reversible
association with eIF4E, the cap binding factor (4, 18, 59). Ngd
is also a CPEB and eIF4E binding protein that can repress
translation in a CPE-dependent manner; whether Ngd inhibi-
tion of translation is reversible, however, is not known.
Ngd is a CPE-dependent eIF4E binding protein. eIF4G and
the 4EBPs (also known as PHAS I) contain a consensus motif,
Y/TXXXXL	, where 	 denotes a hydrophobic amino acid,
that allows them to compete for binding to eIF4E, thereby
controlling initiation (26, 34, 24). Maskin contains this motif,
as does Ngd. While the 4EBPs can repress the translation of
probably most mRNAs by indiscriminately binding eIF4E,
Maskin and Ngd, through tethering to CPEB, control the
translation of only specific mRNAs.
Two additional proteins that contain an eIF4E binding
motif have been reported to resemble Maskin and Ngd by
FIG. 5. Expression of Ngd in Xenopus embryos. (A) Western blots of protein from several stages of Xenopus development probed for Ngd,
Maskin, and actin. The graph on the right shows the relative steady-state levels of Maskin and Ngd. (B) Whole-mount in situ hybridization for Ngd,
slug (a neural crest marker), and nrp-1 (a pan-neural marker) RNAs during Xenopus development.
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repressing specific mRNA translation through an interac-
tion with eIF4E. One of these, Drosophila Bicoid, represses
the translation of uniformly distributed caudal mRNA only
in the anterior region of the embryo. Bicoid, which is itself
localized to the anterior portion of the embryo, accom-
plishes this task not only by binding to a specific sequence in
the 3 UTR of caudal mRNA, the Bicoid response element
(20, 51), but also by interacting with eIF4E, presumably prevent-
ing the eIF4E-eIF4G interaction (44). Because caudal mRNA is
never (properly) translated in the anterior part of the embryo,
Bicoid-mediated repression is probably not reversible. It
should be noted, however, that a recent study indicates that
FIG. 6. Inhibition of ngd mRNA translation results in defects in neuronal and neural crest structures. (A) A rabbit reticuloyte translation system
was primed with Xenopus ngd mRNA as well as a Xenopus ngd morpholino antisense oligonucleotide (Ngd-AM) or a control oligonucleotide (CM);
the amount of Ngd synthesis was monitored by [35S]methionine incorporation and SDS gel electrophoresis. (B) Dorsal views of albino embryos
following injection of ngd antisense or control morpholino oligonucleotides; the left panels show embryo morphology, while the right panels show
the pattern of nrp-1 mRNA. A dotted circle denotes abnormally developed neural tissue. (C and D) Tailbud stage embryos were paraffin
embedded, sectioned, and probed for nrp-1 RNA. Adjacent sections were stained with hematoxylin for general morphology. Arrows denote neural
tube or neural tissue. Scale bars, 50 m in panel C and 100 m in panel D. (E) Quantification of the ngd AM-induced phenotype and rescue with
ngd mRNA. Phenotypes similar to those presented in panels B and C were induced by the Ngd AS in 36% of injected embryos, whereas the CM
induced a phenotype in only 2% of injected embryos; this difference is very highly statistically significant (P  0.001, Student’s t test). Only 18%
of embryos had a similar phenotype when ngd RNA was coinjected with AM; the difference between these samples (i.e., AM plus ngd RNA) is
statistically significant (P 0.05, Student’s t test). Error bars indicate standard deviations. (F) AM- and CM-injected embryos were probed for slug
RNA by whole-mount in situ hybridization. The broken line denotes the dorsal Ngd of the embryo, and the broken circle denotes an area that has
an aberrant morphology and lacks slug RNA-positive tissue. In this assay, 56% of AM-injected embryos, 5% of CM-injected embryos, and 24%
of AM- and ngd RNA-injected embryos (i.e., rescue) had this phenotype.
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Bicoid interacts not with eIF4E but with another cap binding
factor called 4EHP (12).
In another example in Drosophila, nanos mRNA is distrib-
uted throughout the embryo but is more concentrated at the
anterior pole (21, 22, 63), where Nanos protein represses the
translation of hunchback mRNA (21, 65). Unlocalized nanos
mRNA is translationally repressed; this repression requires 3
UTR stem-loop structures known as Smaug response elements
(13, 14, 56, 57). Smaug not only binds these elements but also
associates with Cup, a protein that in turn interacts with eIF4E
and represses translation (43). Cup is thus functionally similar
to Maskin and Ngd. Along these same lines, Cup interacts with
Barentz, a protein that indirectly associates with and represses
oskar mRNA translation in the anterior region of the embryo
(66). Finally, Cup association with the RNA binding protein
Bruno represses oskar mRNA translation during oogenesis
(42). It is not known whether Cup-mediated translational re-
pression is reversible.
Ngd in neurons. In mammalian neurons, Ngd is detected as
puncta in both axons and dendrites but also, perhaps most
interestingly, in growth cones and filopodia. Moreover, in
growth cones from neurons cultured for 3 days, Ngd is colo-
calized with eIF4E (Fig. 3), suggesting that the translation of
one or more mRNAs is regulated at that time in that location.
While neurites at this stage have not yet differentiated into
axons or dendrites, there is little doubt that young growth
cones have the capacity to synthesize protein. Indeed, the
detection of polysomes by electron microscopy (16) and the
incorporation of radiolabeled amino acids into protein into
isolated growth cones (15) demonstrate that translation does
occur in this structure. Moreover, axon turning in vitro in
response to exogenous cures also requires protein synthesis,
although it is not known if this takes place in the growth cone,
the axon shaft, or both (69). Finally, growth cone motility is
reduced if 
-actin mRNA is prevented from localizing to this
region (69), implying that local actin synthesis is necessary
growth cone extension. Such results lead us to suggest that this
protein might mediate mammalian growth cone movement by
regulating local mRNA translation.
Filopodia are thin projections emanating from either den-
dritic shafts or growth cones. While the function of either of
these structures is not known, the former have been suggested
to constitute precursors to synapses or synaptic spines, while
the latter may be involved in activity-dependent growth and/or
branching (45). Ngd immunoreactivity is often associated with
shaft filopodia (Fig. 2), suggesting that regulated mRNA trans-
lation may occur in these structures. Given this result, it is
perhaps surprising that Ngd is not detected in mature synapses
(Fig. 2F), which do support protein synthesis (3, 53). On the
other hand, Maskin immunoreactivity is detected at synapses
(28), perhaps suggesting the replacement of one of these pro-
teins with the other.
Ngd control of neural development. In contrast to the case
for Maskin, no Ngd is detected in Xenopus oocytes and em-
bryos, although they do contain ngd mRNA. In the mouse, Ngd
is first detected at E9 at the roof of the hindbrain and near the
somites (data not shown); in Xenopus, ngd RNA is clearly
observed at stage 25 in the embryonic nervous system, includ-
ing the brain, spinal cord, and dorsal root ganglia. Because
Ngd protein does not appear to be maternally inherited and
because the embryonic expression profile suggests that ngd
mRNA is prevalent in the nervous system (central nervous
system and neural crest), we have injected morpholino-con-
taining antisense oligonucleotides in an attempt to generate an
Ngd loss-of-function mutant embryo. The inhibition of Ngd
expression resulted in an unclosed neural tube, as shown by
using the pan-neural marker nrp-1 (Fig. 6). Importantly, the
mutant phenotype was often rescued when an ngd mRNA that
cannot anneal to the oligonucleotide was coinjected. In a sim-
ilar vein, neural crest cells, identified by the marker slug, did
not properly migrate in embryos injected with the Ngd anti-
sense oligonucleotide. As before, most embryos were rescued
to the wild-type phenotype when an ngd RNA that cannot
anneal to the oligonucleotide was coinjected.
Our challenge is to identify mRNA targets whose translation is
misregulated in the ngd antisense oligonucleotide-injected em-
bryos. Possible targets include those that are involved in anterior-
posterior patterning of the developing nervous system, such as
fibroblast growth factor, Wnts, and mesodermal retinoids (8, 41).
Determining which mRNA(s) is regulated by Ngd in embryos is a
difficult task, since it will be essential to differentiate primary
targets versus those that might only secondarily be affected. We
are therefore exploring several approaches to identify mRNAs
that reside in a complex together with Ngd.
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